MedPath

Comparision of various drugs used inknee osteoarthritis

Phase 4
Completed
Conditions
Health Condition 1: null- Known as well as newly diagnosed cases of primary knee osteoarthritis
Registration Number
CTRI/2016/02/006587
Lead Sponsor
Institute of Medical Sciences Banaras Hindu University Varanasi Uttar Pradesh India
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
217
Inclusion Criteria

Inclusion Criteria:

The patients with radiographic evidence of suffering grade I, II and grade III Osteoarthritis.

The patients having mild to moderate grade of hypertension controlled with therapies as well as those with diabetes well controlled with therapies and suffering from osteoarthritis were also included.

Exclusion Criteria

1.Patients suffering from severe grades of hypertension and diabetes mellitus requiring more than oral hypoglycemic therapies were excluded.

2.Untreated or poorly controlled diabetics and hypertensives were excluded.

3.Patients suffering from any other major systemic disease or active infection were excluded.

4.Patients with H/O trauma to knee in past before or after the onset of osteoarthritic symptoms were excluded.

5.Patients with more advanced (radiological grade IV) OA were excluded.

6.Patients developing any illness causing restriction of routine for one day or more as also those needing more than 3 days course of therapy for emergent illness were excluded.

7.Occasional use of single or two doses of medications up-to two instances during the 12 weeks observational period were allowed.

8.No case of pregnancy or H/O any surgery in last 3 years was included.

9.Patients non-compliant to therapy at more than two recalled occasions during any 2 weeks in treatment course were excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Knee injury and osteoarthritis outcome score (KOOS score)Timepoint: At first visit and at the end of 3 months
Secondary Outcome Measures
NameTimeMethod
nilTimepoint: nil
© Copyright 2025. All Rights Reserved by MedPath